IMNM - Immunome, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$36.20
DETAILS
HIGH:
$40.00
LOW:
$32.00
MEDIAN:
$36.00
CONSENSUS:
$36.20
UPSIDE:
67.13%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 6.9 | 9.0 | 14.0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 3.0 | 0 | 0 | 0 | 0 | 0.8 | 0.6 | 0.5 |
| Gross Profit | 4.0 | 9.0 | 14.0 | 0 | 0 | (0.8) | (0.6) | (0.5) |
| Operating Expenses | ||||||||
| R&D Expenses | 174.3 | 129.5 | 23.1 | 23.3 | 14.1 | 6.7 | 8.8 | 6.9 |
| SG&A Expenses | 43.8 | 33.0 | 19.7 | 13.6 | 11.1 | 4.8 | 1.5 | 0.9 |
| Other Expenses | 0 | 152.3 | 80.8 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 218.1 | 314.8 | 123.5 | 36.9 | 25.2 | 11.5 | 10.3 | 7.7 |
| Operating Income | ||||||||
| Operating Income | (214.1) | (305.8) | (109.5) | (36.9) | (25.2) | (12.3) | (10.3) | (7.7) |
| Interest Expense | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| Interest Income | 11.7 | 12.8 | 2.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profitability | ||||||||
| EBITDA | (211.2) | (151.4) | (28) | (36.3) | (24.4) | (17.0) | (9.7) | (7.2) |
| EBIT | (214.1) | (153.5) | (28.7) | (36.9) | (25.2) | (17.8) | (10.3) | (7.7) |
| Income Before Tax | (212.4) | (293.0) | (106.8) | (36.9) | (24.7) | (17.8) | (10.4) | (7.8) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| Net Income | (212.4) | (293.0) | (106.8) | (36.9) | (24.7) | (17.8) | (10.6) | (7.8) |
| Per Share Data | ||||||||
| EPS (Basic) | -2.43 | -5.00 | -5.38 | -3.09 | -2.14 | -1.69 | -1.84 | -7.18 |
| EPS (Diluted) | -2.43 | -5.00 | -5.38 | -3.09 | -2.14 | -1.69 | -1.84 | -7.18 |
| Shares Outstanding | 87.4 | 58.6 | 19.8 | 12.1 | 11.5 | 10.1 | 5.7 | 1.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 653.5 | 143.4 | 98.7 | 20.3 | 49.2 | 39.8 | 2.5 | 1.6 |
| Short-Term Investments | 0 | 74.0 | 39.5 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0.3 | 0.8 | 4.3 | 0.8 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 7.3 | 4.0 | 5.0 | 0 | 0 | 0 | 0 | 0.5 |
| Total Current Assets | 660.8 | 221.3 | 144.7 | 22.6 | 56.6 | 42.9 | 3.1 | 2.1 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 17.6 | 14.4 | 3.6 | 1.0 | 0.9 | 1.5 | 1.7 | 2.1 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0.2 | 0 | 0.1 | 0 | 0.1 | 0.1 | 0 | 0.1 |
| Other Non-Current Assets | 4.6 | 4.5 | 0.1 | 0.4 | 0.3 | 0 | 0.2 | 0.2 |
| Total Non-Current Assets | 22.4 | 18.9 | 3.8 | 1.4 | 1.3 | 1.6 | 1.9 | 2.3 |
| Total Assets | 683.2 | 240.2 | 148.5 | 24.0 | 57.9 | 44.5 | 5.1 | 4.4 |
| Current Liabilities | ||||||||
| Account Payables | 3.3 | 14.2 | 3.3 | 2.4 | 3.1 | 1.2 | 0.5 | 0.5 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0.5 | 0.2 | 0.2 |
| Deferred Revenue | 0 | 6.9 | 10.5 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 41.7 | 8.0 | 5.0 | 2.0 | 2.0 | 0.5 | 0.4 | 0.1 |
| Total Current Liabilities | 45.0 | 54.3 | 21.8 | 7.3 | 9.7 | 3.0 | 1.7 | 1.6 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 3.9 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0.3 |
| Deferred Tax Liabilities | 0 | 0 | (5.5) | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 5.5 | 0 | 0.0 | 0.0 | 38.9 | 27.5 |
| Total Non-Current Liabilities | 3.9 | 4.8 | 6.8 | 0.1 | 0.0 | 0.1 | 39.0 | 28.1 |
| Total Liabilities | 48.8 | 59.1 | 28.7 | 7.4 | 9.7 | 3.2 | 40.7 | 29.7 |
| Stockholders' Equity | ||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 |
| Retained Earnings | (728.2) | (515.8) | (222.8) | (116.0) | (79.1) | (54.4) | (36.6) | (26.1) |
| Accumulated Other Comprehensive Income | 0 | 0.1 | 0.0 | 0 | (57.9) | (44.5) | 0 | (0.9) |
| Total Stockholders' Equity | 634.3 | 181.2 | 119.9 | 16.7 | 48.2 | 41.3 | (35.6) | (25.2) |
| Total Liabilities & Equity | 683.2 | 240.2 | 148.5 | 24.0 | 57.9 | 44.5 | 5.1 | 4.4 |
| Debt Metrics | ||||||||
| Total Debt | 3.9 | 4.8 | 1.6 | 0.3 | 0.3 | 0.6 | 0.6 | 1.2 |
| Net Debt | (649.6) | (138.5) | (97.0) | (20.0) | (48.9) | (39.2) | (2.0) | (0.4) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (212.4) | (293.0) | (106.8) | (36.9) | (24.7) | (17.8) | (10.4) | (7.8) |
| Depreciation & Amortization | 3.0 | 2.1 | 0.7 | 0.6 | 0.8 | 0.8 | 0.6 | 0.5 |
| Stock-Based Compensation | 25.7 | 15.7 | 6.2 | 5.3 | 3.4 | 0.6 | 0.0 | 0.0 |
| Change in Working Capital | (15.2) | 14.9 | 12.0 | 2.2 | 2.8 | (1.2) | 0.2 | (0.1) |
| Other Non-Cash Items | 8.1 | 149.4 | 80.3 | 7.3 | 0.0 | (0.0) | 0.0 | 0.0 |
| Operating Cash Flow | (190.9) | (110.8) | (7.6) | (28.7) | (18.2) | (12.1) | (9.6) | (7.4) |
| Investing Activities | ||||||||
| Capital Expenditure | (9.7) | (53.5) | (0.8) | (0.2) | (0.1) | (0.6) | (0.2) | (0.2) |
| Acquisitions | 0 | 0 | 9.3 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (123.3) | (186.6) | (38.9) | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 200 | 155 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (6.2) | (46.3) | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 60.8 | (85.1) | (30.5) | (0.2) | (0.1) | (0.6) | (0.2) | (0.2) |
| Financing Activities | ||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | (0.1) | 0.0 | 6.2 | (0.6) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (9.5) | 116.4 | 0 | 0.7 | (6.0) | 0 | 0 |
| Financing Cash Flow | 640.4 | 240.5 | 116.4 | 0.0 | 27.8 | 49.9 | 10.8 | (0.6) |
| Cash Position | ||||||||
| Net Change in Cash | 510.2 | 44.7 | 78.4 | (28.9) | 9.5 | 37.2 | 0.9 | (8.2) |
| Cash at Beginning | 143.5 | 98.8 | 20.4 | 49.3 | 39.9 | 2.6 | 1.6 | 9.9 |
| Cash at End | 653.7 | 143.5 | 98.8 | 20.4 | 49.3 | 39.9 | 2.5 | 1.7 |
| Free Cash Flow | (200.6) | (164.3) | (8.4) | (28.9) | (18.3) | (12.7) | (9.8) | (7.6) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 6.9 | 9.0 | 14.0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 4.0 | 9.0 | 14.0 | 0 | 0 | (0.8) | (0.6) | (0.5) |
| Operating Income | (214.1) | (305.8) | (109.5) | (36.9) | (25.2) | (12.3) | (10.3) | (7.7) |
| Net Income | (212.4) | (293.0) | (106.8) | (36.9) | (24.7) | (17.8) | (10.6) | (7.8) |
| EPS (Diluted) | -2.43 | -5.00 | -5.38 | -3.09 | -2.14 | -1.69 | -1.84 | -7.18 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 653.5 | 143.4 | 98.7 | 20.3 | 49.2 | 39.8 | 2.5 | 1.6 |
| Total Assets | 683.2 | 240.2 | 148.5 | 24.0 | 57.9 | 44.5 | 5.1 | 4.4 |
| Total Debt | 3.9 | 4.8 | 1.6 | 0.3 | 0.3 | 0.6 | 0.6 | 1.2 |
| Stockholders' Equity | 634.3 | 181.2 | 119.9 | 16.7 | 48.2 | 41.3 | (35.6) | (25.2) |
| Cash Flow | ||||||||
| Operating Cash Flow | (190.9) | (110.8) | (7.6) | (28.7) | (18.2) | (12.1) | (9.6) | (7.4) |
| Capital Expenditure | (9.7) | (53.5) | (0.8) | (0.2) | (0.1) | (0.6) | (0.2) | (0.2) |
| Free Cash Flow | (200.6) | (164.3) | (8.4) | (28.9) | (18.3) | (12.7) | (9.8) | (7.6) |